NO953673L - [1,2,4ÅTriazolo[4,3-aÅkinoksalinderivater, deres fremstilling og anvendelse - Google Patents

[1,2,4ÅTriazolo[4,3-aÅkinoksalinderivater, deres fremstilling og anvendelse

Info

Publication number
NO953673L
NO953673L NO953673A NO953673A NO953673L NO 953673 L NO953673 L NO 953673L NO 953673 A NO953673 A NO 953673A NO 953673 A NO953673 A NO 953673A NO 953673 L NO953673 L NO 953673L
Authority
NO
Norway
Prior art keywords
aquinoxaline
derivatives
preparation
aquinoxaline derivatives
Prior art date
Application number
NO953673A
Other languages
English (en)
Other versions
NO305286B1 (no
NO953673D0 (no
Inventor
Poul Jacobsen
Flemming Elmelund Nielsen
Lone Jeppesen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO953673D0 publication Critical patent/NO953673D0/no
Publication of NO953673L publication Critical patent/NO953673L/no
Publication of NO305286B1 publication Critical patent/NO305286B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO953673A 1993-03-19 1995-09-18 Kinoksalinforbindelser, farmas°ytiske preparater som omfatter dem, og anvendelse derav for fremstilling av medikamenter NO305286B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK93310A DK31093D0 (no) 1993-03-19 1993-03-19
PCT/DK1994/000077 WO1994021639A1 (en) 1993-03-19 1994-02-25 [1,2,4] TRIAZOLO [4,3-a] QUINOXALINE DERIVATIVES, THEIR PREPARATION AND USE

Publications (3)

Publication Number Publication Date
NO953673D0 NO953673D0 (no) 1995-09-18
NO953673L true NO953673L (no) 1995-11-17
NO305286B1 NO305286B1 (no) 1999-05-03

Family

ID=8092112

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953673A NO305286B1 (no) 1993-03-19 1995-09-18 Kinoksalinforbindelser, farmas°ytiske preparater som omfatter dem, og anvendelse derav for fremstilling av medikamenter

Country Status (16)

Country Link
US (1) US5559106A (no)
EP (1) EP0691969A1 (no)
JP (1) JPH08507536A (no)
KR (1) KR100313051B1 (no)
CN (1) CN1041930C (no)
AU (1) AU685783B2 (no)
CA (1) CA2158545A1 (no)
DK (1) DK31093D0 (no)
FI (1) FI954386A (no)
HU (1) HUT73419A (no)
IL (1) IL108800A (no)
NO (1) NO305286B1 (no)
NZ (1) NZ262365A (no)
TW (1) TW304195B (no)
WO (1) WO1994021639A1 (no)
ZA (1) ZA941926B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4314592A1 (de) * 1993-04-28 1994-11-03 Schering Ag Benzo(f)chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
ES2146769T3 (es) * 1994-09-16 2000-08-16 Novo Nordisk As Derivados de (1,2,4)triazolo(4,3-a)quinoxalinonas, su preparacion y utilizacion como antagonistas de receptores de ampa.
CZ284930B6 (cs) * 1994-09-16 1999-04-14 Novo Nordisk A/S [1,2,4]triazolo[4,3-a]chinoxalinonové deriváty, jejich příprava a použití
US5679680A (en) * 1995-02-16 1997-10-21 Warner-Lambert Company α-substituted hydrazides having calpain inhibitory activity
FR2743363A1 (fr) * 1996-01-10 1997-07-11 Rhone Poulenc Rorer Sa 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazine-a-ones substituees en position 2, leur preparation et les medicaments les contenant
IL125950A0 (en) * 1997-09-05 1999-04-11 Pfizer Prod Inc Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy
CN1285834A (zh) 1997-11-11 2001-02-28 小野药品工业株式会社 稠合吡嗪化合物
AU2298399A (en) * 1998-02-06 1999-08-23 Yoshitomi Pharmaceutical Industries, Ltd. Novel azapeptide type hydroxamic acid derivatives
US20040152694A1 (en) * 2003-02-04 2004-08-05 Istvan Kurucz Methods and compositions for treating inflammatory disorders of the airways
ES2566774T3 (es) * 2006-12-13 2016-04-15 Aska Pharmaceutical Co., Ltd. Derivado de quinoxalina
KR20110132559A (ko) 2009-03-05 2011-12-08 아스텔라스세이야쿠 가부시키가이샤 퀴녹살린 화합물
EP2338492A1 (en) 2009-12-24 2011-06-29 Universidad del Pais Vasco Methods and compositions for the treatment of alzheimer
JP5822080B2 (ja) * 2010-09-07 2015-11-24 アステラス製薬株式会社 キノキサリン化合物
MX344600B (es) * 2011-06-27 2016-12-20 Janssen Pharmaceutica Nv Derivados de 1-aril-4-metil-[1,2,4]triazolo[4,3-a]quinoxalina.
JP6426603B2 (ja) 2012-06-26 2018-11-21 ヤンセン ファーマシューティカ エヌ．ベー． 神経障害または代謝障害の治療に使用するための、１−アリール−４−メチル−［１，２，４］トリアゾロ［４，３−ａ］−キノキサリン化合物などのＰＤＥ２阻害剤とＰＤＥ１０阻害剤との組合せ

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4354027A (en) * 1980-05-19 1982-10-12 Usv Pharmaceutical Corporation Triazoloquinoxalin-4-ones
US4547501A (en) * 1983-09-02 1985-10-15 Pfizer Inc. Method of using [1,2,4]triazolo[4,3-a]quinoxaline-4-amine derivatives as antidepressant and antifatigue agents
US5153196A (en) * 1991-06-05 1992-10-06 Eli Lilly And Company Excitatory amino acid receptor antagonists and methods for the use thereof
AU3767793A (en) * 1992-04-03 1993-11-08 Yamanouchi Pharmaceutical Co., Ltd. Fused quinoxalinone derivative and pharmaceutical composition containing the same

Also Published As

Publication number Publication date
JPH08507536A (ja) 1996-08-13
NO305286B1 (no) 1999-05-03
US5559106A (en) 1996-09-24
DK31093D0 (no) 1993-03-19
NZ262365A (en) 1997-05-26
ZA941926B (en) 1995-09-18
AU6201894A (en) 1994-10-11
CN1041930C (zh) 1999-02-03
FI954386A0 (fi) 1995-09-18
AU685783B2 (en) 1998-01-29
HUT73419A (en) 1996-07-29
IL108800A0 (en) 1994-06-24
HU9502726D0 (en) 1995-11-28
WO1994021639A1 (en) 1994-09-29
KR100313051B1 (ko) 2002-02-28
IL108800A (en) 1998-02-22
KR960701057A (ko) 1996-02-24
EP0691969A1 (en) 1996-01-17
CN1122601A (zh) 1996-05-15
CA2158545A1 (en) 1994-09-29
TW304195B (no) 1997-05-01
NO953673D0 (no) 1995-09-18
FI954386A (fi) 1995-09-18

Similar Documents

Publication Publication Date Title
NO933434D0 (no) Piperidinderivater, deres fremstilling og anvendelse
NO954369D0 (no) Oksazolidindionderivater, deres fremstilling og anvendelse
DK374389D0 (da) Arylbenzenoxazolidinoner, deres fremstilling og anvendelse
DK609489D0 (da) Imidazolderivater, deres fremstilling og anvendelse
DK1019358T3 (da) 3,3-diarylpropylaminer, deres anvendelse og fremstilling
DK0832104T3 (da) Dolastatinderivater, deres fremstilling og anvendelse
NO943682D0 (no) Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse
NO953673D0 (no) [1,2,4ÅTriazolo[4,3-aÅkinoksalinderivater, deres fremstilling og anvendelse
DK388989A (da) Acylcyanoguanidiner, deres fremstilling og anvendelse
NO895030D0 (no) 2-imino-benzotiazolinderivater og deres fremstilling.
DK435289A (da) Piperazindioner, deres fremstilling og anvendelse
DK473289D0 (da) 2'-halogenmethyliden-, 2'-ethenyliden- og 2'-ethynyl-adenosin-derivater, deres fremstilling og anvendelse
DK60893D0 (da) Piperidinderivater, deres fremstilling og anvendelse
NO954763D0 (no) Piperidinderivater, deres fremstilling og anvendelse
NO933435D0 (no) Piperidinderivater, deres fremstilling og anvendelse
DK73091D0 (da) Quinoxalinforbindelser, deres fremstilling og anvendelse
DK225089D0 (da) 2-adamantyl-4-isothiazolin-3-oner, deres fremstilling og anvendelse
DK469389D0 (da) Piperidinyl-imidazol-derivater, deres fremstilling og anvendelse
NO922992D0 (no) Imid-terminerte polynitrogenforbindelser, deres fremstilling og anvendelse
DK592389D0 (da) Penemderivater, deres fremstilling og anvendelse
NO951812D0 (no) Pyrrolderivater, deres fremstilling og anvendelse
DK455189A (da) 2,3,4,5-tetrahydro-1-benzoxepiner, deres fremstilling og anvendelse
NO920228D0 (no) Polylaktider, deres fremstilling og anvendelse
NO923042D0 (no) 4,5-cykloalkano-3-benzazepin-7-ol-derivater og deres anvendelse
DK0828740T3 (da) 2-Azabicyclo[2.2.1]heptanderivater, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees